MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for December 2018


Multiple Sclerosis (MS) - Market Insights, Epidemiology and Market Forecast-2027
Topics: Multiple Sclerosis (MS)
Global Multiple Sclerosis Partnering 2012 to 2018
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis  -Epidemiology Forecast to 2027
Topics: Multiple Sclerosis (MS), Drug Discovery
Auto-injectors Market Global Forecast by Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types (Prefilled, Fillable), Usability (Reusable, Disposable), Distribution Channels (Online Pharmacies, Retail Pharmacies, Othe
Topics: Allergic Conditions, Multiple Sclerosis (MS), Transdermal & Implantable
Regions: Global
Multiple Sclerosis: Competitive Landscape to 2026
Topics: Multiple Sclerosis (MS)
Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H1, 2018
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Digital Landscape: Multiple Sclerosis
Topics: Multiple Sclerosis (MS)
Regions: Global
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H1, 2018
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2018
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Multiple Sclerosis Global Clinical Trials Review, H1, 2018
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H1, 2018
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
North America and Europe PEGylated Drugs Market Size By Disease Indication (Cancer, Hepatitis, Multiple Sclerosis, Gastrointestinal Disorders), By Type (Monoclonal Antibodies, Colony Stimulating Factors, Interferons), Industry Analysis Report, Regional Ou
Topics: Antibody Technologies, Hepatitis, Cancer Treatment, Multiple Sclerosis (MS), Microbiology & Virology, Oncology/Hematology
Regions: Europe, North America
Medical Affairs Reputations: Multiple Sclerosis (EU5) 2018
Topics: Multiple Sclerosis (MS)
Regions: France, Germany
Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
Topics: Multiple Sclerosis (MS)
Multiple Sclerosis - Pipeline Review, H1 2018
Topics: Multiple Sclerosis (MS), Drug Discovery
Medical Affairs Reputations: Multiple Sclerosis (US) 2018
Topics: Multiple Sclerosis (MS)
Regions: United States
Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2018
Topics: Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2018
Topics: Multiple Sclerosis (MS)
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2018
Topics: Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis  - Market Insight, Epidemiology and Market Forecast - 2027
Topics: Multiple Sclerosis (MS), Drug Discovery
Stem Cell Therapy for Multiple Sclerosis - A Pipeline Analysis report
Topics: Stem Cell, Multiple Sclerosis (MS)
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer’s Disease and SMA Show Clinical and Commercial Potential
Topics: Alzheimer's Disease, Multiple Sclerosis (MS), CNS/Neurology
Regions: Global
Multiple Sclerosis: Update Bulletin #1 [February 2018]
Topics: Multiple Sclerosis (MS)
The 2019-2024 World Outlook for Multiple Sclerosis Therapeutics
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Europe Multiple Sclerosis Market and Competitive Landscape – 2017
Topics: Multiple Sclerosis (MS)
Regions: Europe
Multiple Sclerosis [2016]: Bulletin #3
Topics: Multiple Sclerosis (MS)
Market Access Impact (EU5) [MS]
Topics: Multiple Sclerosis (MS)
Regions: France, Germany
Global Cytokine Market – Growth, Trends and Forecasts (2017 - 2022)
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017
Topics: Multiple Sclerosis (MS)
Regions: Europe
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis [2017]
Topics: Multiple Sclerosis (MS)
Medical Affairs Reputations (US) [MS]
Topics: Multiple Sclerosis (MS)
Regions: United States
China Interferon Industry Report, 2016-2021
Topics: Research & Development, Hepatitis, Multiple Sclerosis (MS)
Regions: China
Central Nervous System (CNS) Therapeutic Market Analysis By Disease Type (Neurovascular Diseases, Trauma, Mental Health, Degenerative Disorder [Alzheimer’s Diseases, Parkinson’s Diseases, Multiple Sclerosis], Infections, Cancer), And Segment Forecasts, 20
Topics: Alzheimer's Disease, Cancer Treatment, Mental Health, Multiple Sclerosis (MS), CNS/Neurology, Oncology/Hematology
Specialty Generics Market Analysis By Type (Injectables, Oral), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C), By End-use, And Segment Forecasts, 2014 - 2025
Topics: Hepatitis, Multiple Sclerosis (MS), Generics Drugs
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Multiple Sclerosis Market and Competitive Landscape – 2017
Topics: Multiple Sclerosis (MS)
Regions: Global
Market Access Impact (US) [MS]
Topics: Multiple Sclerosis (MS)
Regions: United States
Multiple Sclerosis Pipeline Highlights – 2017 Update
Topics: Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing, Drug Discovery
Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017
Topics: Multiple Sclerosis (MS)
Regions: Global
NPS+ (US) [MS]
Topics: Multiple Sclerosis (MS)
Regions: United States
NPS+ (EU5) [MS]
Topics: Multiple Sclerosis (MS)
Regions: France, Germany
Medical Affairs Reputations (EU5) [MS]
Topics: Multiple Sclerosis (MS)
Overcoming Market Access Barriers to High Value Drugs
Topics: AIDS, HIV & STDs, Multiple Sclerosis (MS), Prescription Drugs
Multiple Sclerosis - Payer Insight: Update Bulletin [April 2017]
Topics: Multiple Sclerosis (MS)
Payer Insights: MS [2016]: Bulletin #3
Topics: Multiple Sclerosis (MS)
Real World Data -- Meeting payer needs
Topics: Multiple Sclerosis (MS)
Regions: Global
Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Market Access Impact: Multiple Sclerosis (EU5)
Topics: Multiple Sclerosis (MS)


Prev  | 1  | 2  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.